Related Experiment Video
Updated: May 14, 2026

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi
Yan Xu1, Chuanwen Gao, Xiaohua Li
1Laboratory of Ocular Pharmacology, Henan Eye Institute, Henan Eye Hospital, Zhengzhou, China. xuyan990301@yahoo.com.cn
Purpose:
Fungal keratitis is emerging as a major cause of vision loss in a developing country such as China because of higher incidence and the unavailability of effective antifungals. It is urgent to explore broad-spectrum antifungals to effectively suppress ocular fungal pathogens, and to develop new antifungal eye drops to combat this vision-threatening infection. The aim of this study is to investigate the antifungal activity of silver nanoparticles (nano-Ag) in comparison with that of natamycin against ocular pathogenic filamentous fungi in vitro.
Methods:
Susceptibility tests were performed against 216 strains of fungi isolated from patients with fungal keratitis from the Henan Eye Institute in China by broth dilution antifungal susceptibility test of filamentous fungi approved by the Clinical and Laboratory Standards Institute M38-A document. The isolates included 112 Fusarium isolates (82 Fusarium solani species complex, 20 Fusarium verticillioides species complex, and 10 Fusarium oxysporum species complex), 94 Aspergillus isolates (61 Aspergillus flavus species complex, 11 Aspergillus fumigatus species complex, 12 Aspergillus versicolor species complex, and 10 Aspergillus niger species complex), and 10 Alternaria alternata isolates. The minimum inhibitory concentration (MIC) range and mode, the MIC for 50% of the strains tested (MIC50 value), and the MIC90 value were provided for the isolates with the SPSS statistical package.
Results:
MIC50 value of nano-Ag were 1, 0.5, and 0.5 μg/mL for Fusarium spp., Aspergillus spp., and Al. alternata, respectively. MIC90 values of nano-Ag were 1, 1, and 1 μg/mL for Fusarium spp., Aspergillus spp., and Al. alternata, respectively. MIC50 values of natamycin were 4, 32, and 4 μg/mL for Fusarium spp., Aspergillus spp., and Al. alternata, respectively. MIC90 values of natamycin were 8, 32, and 4 μg/mL for Fusarium spp., Aspergillus spp., and Al. alternata, respectively.
Conclusions:
Nano-Ag, relative to natamycin, exhibits potent in vitro activity against ocular pathogenic filamentous fungi.
Insights
Silver nanoparticles (nano-Ag) show potent antifungal activity against common fungal keratitis pathogens, outperforming the traditional antifungal natamycin in vitro. This finding offers a promising new avenue for developing effective antifungal eye drops to combat vision-threatening fungal eye infections.
Area of Science:
- Ophthalmology
- Mycology
- Nanotechnology
Background:
- Fungal keratitis is a significant cause of vision loss in China.
- Effective antifungal treatments are limited, necessitating the development of new therapeutic options.
- Ocular fungal infections pose a serious threat to vision.
Purpose of the Study:
- To evaluate the in vitro antifungal activity of silver nanoparticles (nano-Ag).
- To compare the efficacy of nano-Ag with natamycin against ocular pathogenic filamentous fungi.
- To explore novel antifungal agents for treating fungal keratitis.
Main Methods:
- Conducted broth dilution antifungal susceptibility tests on 216 fungal isolates from Chinese patients.
- Included Fusarium spp., Aspergillus spp., and Alternaria alternata.
- Determined minimum inhibitory concentration (MIC) values (MIC50 and MIC90) following CLSI M38-A guidelines.
Main Results:
- Silver nanoparticles demonstrated lower MIC50 and MIC90 values against all tested fungal genera compared to natamycin.
- Nano-Ag showed potent activity with MIC50 values of 0.5-1 μg/mL and MIC90 values of 1 μg/mL.
- Natamycin exhibited higher MIC values, indicating less potent activity against these ocular pathogens.
Conclusions:
- Silver nanoparticles exhibit superior in vitro antifungal activity compared to natamycin against ocular pathogenic filamentous fungi.
- Nano-Ag represents a promising candidate for developing new antifungal eye drops.
- Further research into nano-Ag formulations for ocular infections is warranted.
Related Concept Videos
Antifungal Agents
Microbiome of the Eye
